| http://www.w3.org/ns/prov#value | - All statements, other than those of historical fact, contained in this press release, including statements regarding the future expectations, plans and prospects for PTC; the timing of regulatory approvals, the pricing and reimbursement process and Translarna availability ; the development of and potential market for Translarna, including our estimates regarding the size of the nmDMD patient popul
|
